Related Experiment Video
Updated: Jun 5, 2026
08:33
Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
HIV capsid is a tractable target for small molecule therapeutic intervention
Wade S Blair1, Chris Pickford, Stephen L Irving
1Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California, United States of America.
Plos Pathogens
|December 21, 2010
Summary
New antiretroviral compounds targeting the HIV-1 capsid (CA) show potent activity against resistant strains. These small molecules inhibit viral uncoating and assembly, offering a novel therapeutic strategy for HIV treatment.
Area of Science:
- Virology
- Medicinal Chemistry
- Drug Discovery
Background:
- Emergence of multidrug-resistant HIV strains necessitates novel antiretroviral therapies.
- Current standard of care has limitations in combating resistant HIV-1 variants.
Purpose of the Study:
- To report a new class of small molecule antiretroviral compounds targeting HIV-1 capsid (CA).
- To investigate the mechanism of action and antiviral activity of these novel compounds.
Main Methods:
- Antiviral assays against HIV-1 laboratory strains, clinical isolates, and HIV-2.
- Mechanistic studies to determine effects on viral replication cycle (uncoating and assembly).
- Resistance studies involving amino acid substitutions in HIV-1 CA.
- High-resolution co-crystal structure determination of compound bound to HIV-1 CA.
Main Results:
- Compounds exhibit potent antiviral activity across various HIV strains.
- Inhibition of both early (uncoating) and late (assembly) viral replication events.
- HIV-1 CA N-terminal domain mutations confer resistance, confirming CA as the target.
- Novel binding pocket identified in HIV-1 CA N-terminal domain.
Conclusions:
- HIV-1 capsid is a tractable drug target for developing new antiretroviral therapies.
- Targeting the novel CA binding site offers a strategy for broad-spectrum antiviral activity.
- These compounds represent a promising new class of antiretroviral agents.
Related Concept Videos
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...